FORTE BIOSCIENCES, INC. (FBRX)

Every figure this model derived for FBRX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2019-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 198,460,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 203,103,000 AssetsCurrent 2026-06-30
current liabilities 20,289,000 LiabilitiesCurrent 2026-06-30
equity 183,794,000 StockholdersEquity 2026-06-30
interest expense 3,823,000 InterestExpenseDebt 2020-03-31
revenue 36,000 RevenueFromContractWithCustomerExcludingAssessedTax 2019-12-31
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up FBRX on one particular measure came for.

RatioValue
current ratio10.01
current ratio reported10.01
deferred revenue growth-75.0
ev sales39887.98
growth cv1.42
revenue growth-99.8
revenue growth per share-99.8
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about FBRX's figures. Written by the derivation as it ran, not added afterwards.